These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21469198)

  • 21. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
    Chabás A; Gort L; Díaz-Font A; Montfort M; Santamaría R; Cidrás M; Grinberg D; Vilageliu L
    Blood Cells Mol Dis; 2005; 35(2):253-8. PubMed ID: 15967693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of Parkinson's disease in type 1 Gaucher disease.
    Bultron G; Kacena K; Pearson D; Boxer M; Yang R; Sathe S; Pastores G; Mistry PK
    J Inherit Metab Dis; 2010 Apr; 33(2):167-73. PubMed ID: 20177787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tef polymorphism is associated with sleep disturbances in patients with Parkinson's disease.
    Hua P; Liu W; Zhao Y; Ding H; Wang L; Xiao H
    Sleep Med; 2012 Mar; 13(3):297-300. PubMed ID: 22257907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
    Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
    Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
    Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-morbidity in Gaucher's disease results of a nationwide enquiry in Spain.
    Pérez-Calvo J; Bernal M; Giraldo P; Torralba MA; Civeira F; Giralt M; Pocovi M
    Eur J Med Res; 2000 Jun; 5(6):231-5. PubMed ID: 10882637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
    Torralba MA; Pérez-Calvo JI; Pastores GM; Cenarro A; Giraldo P; Pocoví M
    Blood Cells Mol Dis; 2001; 27(2):489-95. PubMed ID: 11259172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value.
    Boot RG; Hollak CE; Verhoek M; Sloof P; Poorthuis BJ; Kleijer WJ; Wevers RA; van Oers MH; Mannens MM; Aerts JM; van Weely S
    Hum Mutat; 1997; 10(5):348-58. PubMed ID: 9375849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.
    Satake W; Mizuta I; Suzuki S; Nakabayashi Y; Ito C; Watanabe M; Takeda A; Hasegawa K; Sakoda S; Yamamoto M; Hattori N; Murata M; Toda T
    Neuroreport; 2007 Jun; 18(9):937-40. PubMed ID: 17515805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Synuclein rs356219 polymorphisms in patients with Gaucher disease and Parkinson disease.
    Altarescu G; Ioscovich D; Alcalay RN; Zimran A; Elstein D
    Neurosci Lett; 2014 Sep; 580():104-7. PubMed ID: 25111979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia.
    Emelyanov A; Boukina T; Yakimovskii A; Usenko T; Drosdova A; Zakharchuk A; Andoskin P; Dubina M; Schwarzman A; Pchelina S
    Mov Disord; 2012 Jan; 27(1):158-9. PubMed ID: 21915911
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of the glucocerebrosidase gene in Parkinson's disease.
    Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E
    Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of 12 new mutations in Gaucher disease Brazilian patients.
    Rozenberg R; Fox DC; Sobreira E; Pereira LV
    Blood Cells Mol Dis; 2006; 37(3):204-9. PubMed ID: 17059888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the c.(-203)A>G variant in the glucocerebrosidase gene and its association with phenotype in Gaucher disease.
    Alfonso P; Pampín S; García-Rodríguez B; Tejedor T; Domínguez C; Rodríguez-Rey JC; Giraldo P; Pocoví M
    Clin Chim Acta; 2011 Jan; 412(3-4):365-9. PubMed ID: 21087600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of SCARB2 as susceptibility factor in Parkinson's disease.
    Hopfner F; Schulte EC; Mollenhauer B; Bereznai B; Knauf F; Lichtner P; Zimprich A; Haubenberger D; Pirker W; Brücke T; Peters A; Gieger C; Kuhlenbäumer G; Trenkwalder C; Winkelmann J
    Mov Disord; 2013 Apr; 28(4):538-40. PubMed ID: 23408458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association between the debrisoquine hydroxylase gene polymorphism and the genetic susceptibility of Parkinson's disease].
    Tao E; Liu Z; Chen B; Pan X; Shao M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):281-3. PubMed ID: 9758873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher disease.
    Lieblich M; Altarescu G; Zimran A; Elstein D
    Blood Cells Mol Dis; 2011 Jan; 46(1):92-4. PubMed ID: 20920864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.